Home Find a Provider Find a Provider Andrew Cameron, Ph.D.

Andrew Cameron, Ph.D.

Contact

Office (585) 758-0513

View Contact & Scheduling

About Me
Credentials
Research
Publications

About Me

Professional Background

Andrew Cameron, Ph.D., is a faculty member in the Department of Pathology and Laboratory Medicine and Assistant Director of the Clinical Microbiology Laboratories at the UR Medicine Central Laboratory. As a board-certified Clinical Microbiologist, he is a Diplomate of the American Board of Medical Microbiology.

Dr. Cameron completed his Ph.D at the University of British Columbia, Vancouver, BC, Canada, where he studied the pathogenesis and high-frequency variation of the gastrointestinal pathogen Campylobacter jejuni. He completed post-doctoral training at the University of Calgary and the Government of Canada, where he studied the genomics of bacterial pathogens. Most recently, Dr. Cameron completed a Fellowship in Medical and Public Health Microbiology at the University of Rochester Medical Center.

Faculty Appointments

Assistant Professor - Department of Pathology and Laboratory Medicine (SMD)

Credentials

Post-doctoral Training & Residency

CPEP Medical and Public Health Microbiology (American Society for Microbiology). University of Rochester Medical Center 2019 - 2021

Post-doctoral Fellowship (Natural Sciences and Engineering Research Council of Canada). University of Calgary 2016 - 2019

Post-doctoral Research Program (Agriculture and Agri-Food Canada). Government of Canada 2015 - 2019

Education

PhD | Canada - University of British Columbia. Microbiology and Immunology. 2015

BSc | Canada - University of British Columbia. Microbiology and Immunology. 2009

Research

Dr. Cameron has >10 years' experience in microbiology research. His research interests include whole-genome sequencing and comparative genomics of bacterial pathogens. He is currently involved in whole-genome sequencing of SARS-CoV-2.

Publications

Journal Articles

Simultaneous Measurement of IgM and IgG Antibodies to SARS-CoV-2 Spike, RBD, and Nucleocapsid Multiplexed in a Single Assay on the xMAP INTELLIFLEX DR-SE Flow Analyzer.

Cameron A, Bohrhunter JL, Porterfield CA, Mangat R, Karasick MH, Pearson Z, Angeloni S, Pecora ND

Microbiology spectrum.. 2022 April 2710 (2):e0250721. Epub 04/07/2022.

Painful Purulent Nodules Caused by Mycobacterium at Site of Lipodissolve Injections.

Kaur H, Reyes-Barron C, Sipprell WH, Cameron A, Louie T, Tsai PR, Scott G

The American Journal of dermatopathology.. 2022 April 144 (4):257-259. Epub 1900 01 01.

IgG Against Human ?-Coronavirus Spike Proteins Correlates with SARS-CoV-2 anti-Spike IgG Responses and COVID-19 Disease Severity.

Wang J, Li D, Cameron A, Zhou Q, Wiltse A, Nayak J, Pecora ND, Zand MS

The Journal of infectious diseases.. 2022 January 29 Epub 01/29/2022.

Human Disease Caused by Kalamiella piersonii

Alpizar-Rivas, R.; Cameron, A.; Hay, C.

IMClinicalCases. 2022; 1(e210220).

Detection of CTX-M-27 ?-lactamase genes on two distinct plasmid types in ST38 from three US states.

Cameron A, Mangat R, Taffner S, Wang J, Dumyati G, Stanton RA, Daniels JB, Campbell D, Lutgring JD, Pecora ND

Antimicrobial agents and chemotherapy.. 2021 May 10 Epub 05/10/2021.

A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System.

Angeloni S, Cameron A, Pecora ND, Dunbar S

Journal of visualized experiments : JoVE.. 2021 April 6 (170)Epub 04/06/2021.

AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 EUA and LDT Serologic Testing in Clinical Laboratories.

Zhang YV, Wiencek J, Meng QH, Theel ES, Babic N, Sepiashvili L, Pecora ND, Slev P, Cameron A, Konforte D,

Clinical chemistry.. 2021 March 24 Epub 03/24/2021.

Extraction-Free Methods for the Detection of SARS-CoV-2 by Reverse Transcription-PCR: a Comparison with the Cepheid Xpert Xpress SARS-CoV-2 Assay across Two Medical Centers.

Cameron A, Pecora ND, Pettengill MA

Journal of clinical microbiology.. 2021 January 2159 (2)Epub 01/21/2021.

Clinical Pathogen Genomics.

Cameron A, Bohrhunter JL, Taffner S, Malek A, Pecora ND

Clinics in laboratory medicine.. 2020 December 40 (4):447-458. Epub 10/01/2020.

A multiplex microsphere IgG assay for SARS-CoV-2 using ACE2-mediated inhibition as a surrogate for neutralization.

Cameron A, Porterfield CA, Byron LD, Wang J, Pearson Z, Bohrhunter JL, Cardillo AB, Ryan-Muntz L, Sorensen RA, Caserta MT, Angeloni S, Hardy DJ, Zand MS, Pecora ND

Journal of clinical microbiology.. 2020 November 2 Epub 11/02/2020.

Surveillance of Enterococcus spp. reveals distinct species and antimicrobial resistance diversity across a One-Health continuum.

Zaheer R, Cook SR, Barbieri R, Goji N, Cameron A, Petkau A, Polo RO, Tymensen L, Stamm C, Song J, Hannon S, Jones T, Church D, Booker CW, Amoako K, Van Domselaar G, Read RR, McAllister TA

Scientific reports.. 2020 March 310 (1):3937. Epub 03/03/2020.

Genomic Surveillance of Ceftriaxone-Resistant in Western New York Suggests the Extended-Spectrum ?-Lactamase Is Emerging on Distinct Plasmids in ST38.

Mostafa HH, Cameron A, Taffner SM, Wang J, Malek A, Dumyati G, Hardy DJ, Pecora ND

Frontiers in microbiology.. 2020 11 :1747. Epub 07/30/2020.

Could probiotics be the panacea alternative to the use of antimicrobials in livestock diets?

Cameron A, McAllister TA

Beneficial microbes.. 2019 October 1410 (7):773-799. Epub 08/27/2019.

Invited review: Application of meta-omics to understand the dynamic nature of the rumen microbiome and how it responds to diet in ruminants.

Gruninger RJ, Ribeiro GO, Cameron A, McAllister TA

Animal : an international journal of animal bioscience.. 2019 September 13 (9):1843-1854. Epub 05/07/2019.

Bacteriocin Occurrence and Activity in Isolated from Bovines and Wastewater.

Cameron A, Zaheer R, Adator EH, Barbieri R, Reuter T, McAllister TA